Nanoparticles built from red blood cell membranes and loaded with a sound-sensitive dye kill liver cancer cells when triggered by ultrasound while remaining nontoxic without activation.
Reducing protein intake may slow the progression of liver cancer, according to a study that reveals how ammonia fuels tumors.
A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...
Medindia on MSN
Low-Protein Diet Linked to Slower Liver Tumor Growth
India, March 25 -- A Science Advances lab-based study has found that lowering dietary protein slowed liver tumor growth and improved survival in mice with impaired ammonia clearance, pointing to a ...
Scientists warn that if your liver does not function correctly then it is important to reduce your protein intake to lower ...
Something as everyday as protein intake can shift the balance in a damaged liver, turning a normal waste product into ...
Individuals with healthy liver function typically process ammonia efficiently, converting it into urea for elimination. However, those with liver conditions such as hepatitis, fatty liver disease, ...
While there are currently no approved perioperative treatments for liver cancer, multiple late-stage trials are evaluating immunotherapy-based strategies in this setting.
Researchers have found that reducing dietary protein may help slow liver tumour growth, particularly in cases where the liver is unable to properly clear ammonia due to damage. The study, led by ...
News9Live on MSN
Lower protein intake may slow liver tumour growth in damaged livers, says study published in Science Advances
A Science Advances study led by Rutgers University researchers finds that lowering dietary protein slowed liver tumour growth ...
A new study suggests that suppressing a cellular enzyme long considered protective against fatty liver disease could have unexpected long-term consequences.
Marked interindividual variability in organ size at comparable BMI supports organ dimensions as a potentially superior predictor of kidney, liver, and pancreatic cancer risk than BMI alone. Ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results